Razagilin Makpharm 1 mg tablete
| Name | Razagilin Makpharm 1 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-765665115 |
| Active Substance | razagilintartarat |
| Composition | svaka tableta sadrži 1 mg razagilina (u obliku tartarata) |
| Pharmaceutical Form | tableta |
| Manufacturer | Synthon Hispania S.L., Barcelona, Španjolska Synthon s.r.o., Blansko, Češka Synthon BV, Nijmegen, Nizozemska |
| Marketing Authorisation Holder | Makpharm d.o.o., Trnjanska cesta 37/1, Zagreb, Hrvatska |
| Marketing Authorisation Date | 02.07.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/20-02/16 |
| Registration Number | 381-12-01/70-20-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | N04BD02 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
